ENXTPA:SANPharmaceuticals
Are Sanofi Shares Offering Hidden Value After Pipeline Expansion News in 2025?
Ever wondered if Sanofi stock is genuinely undervalued or just flying under the radar? Let’s break down what’s really happening beneath the surface so you can decide with confidence.
Sanofi’s share price has slipped by 2.5% over the past week, but it has seen a mild rebound of 1.0% over the last month, amidst a longer-term dip of 9.4% year-to-date.
Recent headlines have centered on Sanofi’s steps to advance its drug pipeline, as well as strategic moves in partnerships and market expansion...